MiR-519d suppresses trophoblast cell invasion and migration by downregulating MMP2 [41], suppresses breast cancer by inhibiting STAT3 expression [35], and inhibits tumor metastasis and MMP2 expression in chondrosarcoma and osteosarcoma [36–37]. Here, STAT3 is linked to breast carcinoma.